Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter phase II study of single-dose pegfilgrastim with R-FC or FC chemotherapy in chronic lymphocytic leukemia
KCT0002087Phase 2Recruiting
- Sponsor
- Kyowa Kirin
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Kyowa Kirin. Started Mar 2016; status: recruiting.
02
Drugs
pegfilgrastim
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on KCT0002087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002087.